Skip to content
Global sound
Oncology news updates

Oncology news updates

by Oncology Brothers

Latest episode
Oncology Brothers Expert Discussion with Dr. John Mascarenhas

About this podcast

To provide additional clinical perspective on the SURPASS-ET findings, Oncology Brothers hosted a dedicated podcast discussion with Dr. John Mascarenhas, a recognized MPN specialist from Mount Sinai. During the episode, Dr. Mascarenhas shared his clinical perspective on the FDA approval of ropeginterferon alfa-2b for essential thrombocythemia, the design and outcomes of the SURPASS-ET study, and how the treatment compares with anagrelide. The conversation also explored disease modification, JAK2 allele burden, treatment dosing, management of adverse effects, and considerations for younger patients. By bringing an MPN specialist into an in-depth discussion of the latest clinical evidence, the podcast provides healthcare professionals and other interested readers with an additional expert perspective on the evolving treatment landscape of essential thrombocythemia.

Episodes

Live, last hour: 8,355 songs on 4,133 stations in 119 countries

Discover the world through radio

More ways to discover (9)

Heard something good? Save it, or open it straight away in Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
Radio 538 luisteren - Live!Popular right now